Therapy for status epilepticus.
Recent advances in understanding the pathophysiology of status epilepticus (SE) have increased the urgency with which the study of this disorder should be approached. The clinical pharmacology of anticonvulsants useful in treating SE is reviewed and their application in several of the different types of SE is discussed. The potential for future advances is briefly considered.
D000086:Acetazolamide / Q000627:therapeutic use; D000758:Anesthesia; D000927:Anticonvulsants / Q000627:therapeutic use; D001463:Barbiturates; D002719:Chlormethiazole / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D005013:Ethosuximide / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D010242:Paraldehyde / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D013226:Status Epilepticus / Q000145:classification / Q000188:drug therapy*; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D001463:Barbiturates; D002719:Chlormethiazole; D002998:Clonazepam; D005013:Ethosuximide; D014635:Valproic Acid; D010672:Phenytoin; D008012:Lidocaine; D008140:Lorazepam; D000086:Acetazolamide; D003975:Diazepam; D010242:Paraldehyde; D010634:Phenobarbital